Status:
COMPLETED
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Preterm Delivery
Eligibility:
FEMALE
16-45 years
Phase:
PHASE2
Brief Summary
Preterm birth remains a major cause of perinatal morbidity and mortality in developing as well as in developed countries. Despite major clinical research efforts aimed at reducing the incidence of pre...
Detailed Description
Preterm birth remains the leading public health problem in obstetrics. A recent analysis of neonatal mortality (death at age \< 28 days) in the United States between 1989 and 2001 revealed that preter...
Eligibility Criteria
Inclusion
- Viable twin pregnancy
- Current pregnancy between 16 weeks and 20 weeks of gestation
Exclusion
- Known fetal anomaly in either twin
- Current or planned cervical cerclage
- Hypertension requiring medication
- Diabetes Mellitus
- Asthma
- History of deep vein thrombosis
- Preexisting cardiac or renal disease
- A seizure disorder
- Plans to deliver elsewhere
- Previous or existing liver tumors
- History of herpes gestationis of pregnancy
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT00141908
Start Date
October 1 2006
End Date
December 1 2012
Last Update
July 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut
Beirut, Lebanon